1. Home
  2. XHLD vs MRKR Comparison

XHLD vs MRKR Comparison

Compare XHLD & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XHLD
  • MRKR
  • Stock Information
  • Founded
  • XHLD 2011
  • MRKR N/A
  • Country
  • XHLD United States
  • MRKR United States
  • Employees
  • XHLD N/A
  • MRKR N/A
  • Industry
  • XHLD
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • XHLD
  • MRKR Health Care
  • Exchange
  • XHLD NYSE
  • MRKR Nasdaq
  • Market Cap
  • XHLD 17.6M
  • MRKR 19.1M
  • IPO Year
  • XHLD 2025
  • MRKR N/A
  • Fundamental
  • Price
  • XHLD $0.43
  • MRKR $1.45
  • Analyst Decision
  • XHLD Strong Buy
  • MRKR Strong Buy
  • Analyst Count
  • XHLD 1
  • MRKR 3
  • Target Price
  • XHLD $8.00
  • MRKR $13.17
  • AVG Volume (30 Days)
  • XHLD 665.4K
  • MRKR 235.1K
  • Earning Date
  • XHLD 05-20-2025
  • MRKR 08-13-2025
  • Dividend Yield
  • XHLD N/A
  • MRKR N/A
  • EPS Growth
  • XHLD N/A
  • MRKR N/A
  • EPS
  • XHLD N/A
  • MRKR N/A
  • Revenue
  • XHLD $3,115,000.00
  • MRKR $5,696,123.00
  • Revenue This Year
  • XHLD $42.64
  • MRKR N/A
  • Revenue Next Year
  • XHLD $65.31
  • MRKR $11.28
  • P/E Ratio
  • XHLD N/A
  • MRKR N/A
  • Revenue Growth
  • XHLD N/A
  • MRKR 71.53
  • 52 Week Low
  • XHLD $0.40
  • MRKR $0.95
  • 52 Week High
  • XHLD $8.54
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • XHLD N/A
  • MRKR 50.31
  • Support Level
  • XHLD N/A
  • MRKR $1.46
  • Resistance Level
  • XHLD N/A
  • MRKR $1.94
  • Average True Range (ATR)
  • XHLD 0.00
  • MRKR 0.20
  • MACD
  • XHLD 0.00
  • MRKR -0.02
  • Stochastic Oscillator
  • XHLD 0.00
  • MRKR 40.24

About XHLD TEN HOLDINGS INC

TEN Holdings Inc is a provider of event planning, production, and broadcasting services. The company produces virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by its Xyvid Pro Platform. Physical events involve live streaming and video recording of physical events. The Company operates business as one operating segment which includes two revenue types: Hybrid and Virtual Events and Physical Events.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: